PFE/Merck-KGaA—FDA approves Bavencio (avelumab) for Merkel cell carcinoma: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm548278.htm Bavencio is under FDA review in second-line bladder cancer with a PDUFA date of 8/27/17 (#msg-129066932). Please see #msg-126858782 for additional info on this drug.